Literature DB >> 11733385

Immunological consequences of topical bovine thrombin.

J L Zehnder, L L Leung.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11733385      PMCID: PMC1850577          DOI: 10.1016/S0002-9440(10)63086-6

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  6 in total

1.  Clinical significance of antibodies to bovine and human thrombin and factor V after surgical use of bovine thrombin.

Authors:  S I Rapaport; A Zivelin; R A Minow; C S Hunter; K Donnelly
Journal:  Am J Clin Pathol       Date:  1992-01       Impact factor: 2.493

2.  Development of antibodies to thrombin and factor V with recurrent bleeding in a patient exposed to topical bovine thrombin.

Authors:  J L Zehnder; L L Leung
Journal:  Blood       Date:  1990-11-15       Impact factor: 22.113

3.  Exposure of mice to topical bovine thrombin induces systemic autoimmunity.

Authors:  J G Schoenecker; R K Johnson; A P Lesher; J D Day; S D Love; M R Hoffman; T L Ortel; W Parker; J H Lawson
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

4.  Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin.

Authors:  T L Ortel; M C Mercer; E H Thames; K D Moore; J H Lawson
Journal:  Ann Surg       Date:  2001-01       Impact factor: 12.969

5.  Iatrogenic immunization with bovine thrombin: a mechanism for prolonged thrombin times after surgery.

Authors:  M J Flaherty; R Henderson; M H Wener
Journal:  Ann Intern Med       Date:  1989-10-15       Impact factor: 25.391

6.  Development of antithrombin antibodies following surgery in patients with prosthetic cardiac valves.

Authors:  R B Stricker; P K Lane; J D Leffert; G M Rodgers; M A Shuman; L Corash
Journal:  Blood       Date:  1988-10       Impact factor: 22.113

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.